$KOSS
KOSS CORP

2020 Form 10-K Financial Statement

#000143774920018841 Filed on August 27, 2020

View on sec.gov

Income Statement

Concept 2020 2019 Q2 2019
Revenue $18.31M $5.790M $21.84M
YoY Change -16.16% -20.03% -7.12%
Cost Of Revenue $12.65M $4.110M $15.02M
YoY Change -15.8% -20.66% -11.46%
Gross Profit $5.663M $1.670M $6.820M
YoY Change -16.97% -18.93% 4.02%
Gross Profit Margin 30.92% 28.84% 31.22%
Selling, General & Admin $6.147M $1.650M $6.544M
YoY Change -6.07% -4.07% -5.44%
% of Gross Profit 108.55% 98.8% 95.95%
Research & Development $397.4K
YoY Change
% of Gross Profit 7.02%
Depreciation & Amortization $330.6K $90.00K $429.8K
YoY Change -23.06% -35.71% -18.34%
% of Gross Profit 5.84% 5.39% 6.3%
Operating Expenses $6.544M $1.660M $6.544M
YoY Change 0.01% -3.49% -10.94%
Operating Profit -$484.0K $10.00K $276.3K
YoY Change -275.18% -97.06% -175.88%
Interest Expense $20.19K $0.00 $3.178K
YoY Change 535.15% -39.1%
% of Operating Profit 0.0% 1.15%
Other Income/Expense, Net
YoY Change
Pretax Income -$463.9K $20.00K $279.5K
YoY Change -265.97% -94.12% -175.66%
Income Tax $1.740K $0.00 -$26.50K
% Of Pretax Income 0.0% -9.48%
Net Earnings -$465.6K $20.00K $306.0K
YoY Change -252.16% -94.29% -108.97%
Net Earnings / Revenue -2.54% 0.35% 1.4%
Basic Earnings Per Share -$0.06 $0.04
Diluted Earnings Per Share -$0.06 $2.699K $0.04
COMMON SHARES
Basic Shares Outstanding 7.405M 7.405M shares 7.401M
Diluted Shares Outstanding 7.405M 7.408M

Balance Sheet

Concept 2020 2019 Q2 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.000M $2.230M $2.230M
YoY Change 79.37% 106.48% 106.48%
Cash & Equivalents $4.000M $2.228M $2.230M
Short-Term Investments
Other Short-Term Assets $270.0K $130.0K $130.0K
YoY Change 107.69% -38.1% -38.1%
Inventory $5.540M $6.851M $6.850M
Prepaid Expenses
Receivables $2.320M $3.655M $3.660M
Other Receivables $10.00K $40.00K $40.00K
Total Short-Term Assets $12.14M $12.91M $12.91M
YoY Change -5.96% 6.12% 6.08%
LONG-TERM ASSETS
Property, Plant & Equipment $3.570M $890.1K $3.740M
YoY Change -4.55% -21.38% -11.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.880M $9.431M $6.580M
YoY Change 4.56% -0.48% 3.3%
Total Long-Term Assets $10.44M $10.32M $10.33M
YoY Change 1.06% -2.71% -2.64%
TOTAL ASSETS
Total Short-Term Assets $12.14M $12.91M $12.91M
Total Long-Term Assets $10.44M $10.32M $10.33M
Total Assets $22.58M $23.24M $23.24M
YoY Change -2.84% 2.01% 2.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $830.0K $1.436M $1.440M
YoY Change -42.36% 0.48% 0.7%
Accrued Expenses $860.0K $650.5K $920.0K
YoY Change -6.52% -17.55% -11.54%
Deferred Revenue $645.5K
YoY Change -6.58%
Short-Term Debt $510.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.620M $2.998M $3.000M
YoY Change -12.67% -5.25% -5.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.810M $5.170M $5.170M
YoY Change -6.96% -4.44%
Total Long-Term Liabilities $4.810M $5.165M $5.170M
YoY Change -6.96% -4.53% -4.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.620M $2.998M $3.000M
Total Long-Term Liabilities $4.810M $5.165M $5.170M
Total Liabilities $7.420M $8.163M $8.160M
YoY Change -9.07% -4.79% -4.78%
SHAREHOLDERS EQUITY
Retained Earnings $8.702M
YoY Change 3.42%
Common Stock $6.370M
YoY Change 10.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.16M $15.07M $15.07M
YoY Change
Total Liabilities & Shareholders Equity $22.58M $23.24M $23.24M
YoY Change -2.84% 2.01% 2.02%

Cashflow Statement

Concept 2020 2019 Q2 2019
OPERATING ACTIVITIES
Net Income -$465.6K $20.00K $306.0K
YoY Change -252.16% -94.29% -108.97%
Depreciation, Depletion And Amortization $330.6K $90.00K $429.8K
YoY Change -23.06% -35.71% -18.34%
Cash From Operating Activities $1.802M -$430.0K $1.411M
YoY Change 27.68% -12.24% 36.85%
INVESTING ACTIVITIES
Capital Expenditures $424.2K -$70.00K $187.8K
YoY Change 125.91% -25.08%
Acquisitions
YoY Change
Other Investing Activities -$110.0K $0.00 -$120.0K
YoY Change -8.33% -7.69%
Cash From Investing Activities -$537.3K -$70.00K -$311.0K
YoY Change 72.76% -18.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 506.7K 0.000 46.68K
YoY Change 985.55%
NET CHANGE
Cash From Operating Activities 1.802M -430.0K 1.411M
Cash From Investing Activities -537.3K -70.00K -311.0K
Cash From Financing Activities 506.7K 0.000 46.68K
Net Change In Cash 1.771M -500.0K 1.147M
YoY Change 54.45% 2.04% 76.63%
FREE CASH FLOW
Cash From Operating Activities $1.802M -$430.0K $1.411M
Capital Expenditures $424.2K -$70.00K $187.8K
Free Cash Flow $1.378M -$360.0K $1.223M
YoY Change 12.61% -26.53% 56.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000056701
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Registrant Name
EntityRegistrantName
KOSS CORP
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Trading Symbol
TradingSymbol
koss
CY2020Q2 koss Cooperative Advertising And Promotion Allowances
CooperativeAdvertisingAndPromotionAllowances
158770
CY2019Q2 koss Cooperative Advertising And Promotion Allowances
CooperativeAdvertisingAndPromotionAllowances
188985
CY2020 koss Effective Income Tax Rate Reconciliation Adjustment To Deferred Tax Assets Amount
EffectiveIncomeTaxRateReconciliationAdjustmentToDeferredTaxAssetsAmount
44790
CY2019 koss Effective Income Tax Rate Reconciliation Adjustment To Deferred Tax Assets Amount
EffectiveIncomeTaxRateReconciliationAdjustmentToDeferredTaxAssetsAmount
189186
CY2020 koss Effective Income Tax Rate Reconciliation Current Year Permanent Items Amount
EffectiveIncomeTaxRateReconciliationCurrentYearPermanentItemsAmount
35931
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceLowerLimit
2.63
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceLowerLimit
1.97
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceUpperLimit
2.92
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceUpperLimit
2.17
CY2018Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.77
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.77
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.77
CY2019 koss Effective Income Tax Rate Reconciliation Current Year Permanent Items Amount
EffectiveIncomeTaxRateReconciliationCurrentYearPermanentItemsAmount
14687
CY2020 koss Lease Extension Per Year
LeaseExtensionPerYear
380000
CY2020Q2 koss Recognition Of Deferred Revenue Amortization In First Year
RecognitionOfDeferredRevenueAmortizationInFirstYear
0.5
CY2020Q2 koss Recognition Of Deferred Revenue Amortization In Second Year
RecognitionOfDeferredRevenueAmortizationInSecondYear
0.3
CY2020Q2 koss Recognition Of Deferred Revenue Amortization In Third Year
RecognitionOfDeferredRevenueAmortizationInThirdYear
0.2
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceLowerLimit
1.77
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceLowerLimit
1.77
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceUpperLimit
6.28
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceUpperLimit
6
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceLowerLimit
1.77
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceUpperLimit
2.24
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceLowerLimit
1.77
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceLowerLimit
2.20
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceUpperLimit
5.83
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceUpperLimit
6.28
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceLowerLimit
1.77
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceLowerLimit
1.77
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceUpperLimit
2.65
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceUpperLimit
2.65
CY2019Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
65937
CY2018Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
6.28
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
6.28
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
6
CY2019Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
60178
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
827705
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1436373
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2317064
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3655143
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
8098
CY2019Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
18694
CY2020Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
80399
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
580099
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
650513
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
68200
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
65914
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
53647
CY2019Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
51026
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7946531
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7716695
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6333135
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6882729
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6333135
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
515681
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
549594
CY2020Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
16363
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74082
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2617
CY2020Q2 us-gaap Assets
Assets
22580406
CY2019Q2 us-gaap Assets
Assets
23235282
CY2020Q2 us-gaap Assets Current
AssetsCurrent
12137536
CY2019Q2 us-gaap Assets Current
AssetsCurrent
12914422
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3999409
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2228282
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2228282
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1081533
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3999409
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1771127
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1146749
CY2020Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
6876827
CY2019Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
6569628
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7404831
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7382706
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7404831
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7382706
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
37024
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
37024
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
427193
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
497351
CY2018Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
859370
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
423639
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
645470
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
170281
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
163018
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12649222
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15022223
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-15037
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-13277
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3501
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
25
CY2020 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
150000
CY2019 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
150000
CY2020Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2333482
CY2019Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2419962
CY2020Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
150000
CY2019Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
150000
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
13276
CY2019 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-13251
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13276
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13276
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13276
CY2020Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
146841
CY2019Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
202102
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2508
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
15481
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
606730
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
558117
CY2020Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
134045
CY2019Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
122714
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
216484
CY2019Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
139504
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
614018
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
642424
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
249313
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
228981
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
479112
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
503726
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2444035
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2382087
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2710628
CY2020Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2508
CY2019Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2205
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
252293
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
160171
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.75
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.5
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
330629
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
429750
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
9198
CY2020 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0
CY2019 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0
CY2020 us-gaap Gross Profit
GrossProfit
5662608
CY2019 us-gaap Gross Profit
GrossProfit
6819874
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-463857
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
279486
CY2020 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2019 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1740
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26503
CY2020Q2 us-gaap Liabilities
Liabilities
7424308
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
61948
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-328541
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
18962
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-97409
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
85599
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-12639
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
19087
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-30040
CY2019 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
8433
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2765
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
20
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
22568
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
15000
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
14622
CY2019Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
45660
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-608668
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6882
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1281693
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1031180
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-70414
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-138448
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-214568
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-50882
CY2020 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
63520
CY2019 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
175953
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-31038
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
13285
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1312654
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
712769
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
133758
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-72887
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6797
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
20185
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3178
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5149200
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6604408
CY2020Q2 us-gaap Inventory Gross
InventoryGross
7102231
CY2019Q2 us-gaap Inventory Gross
InventoryGross
8452748
CY2019Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
0
CY2017Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
0
CY2020Q2 us-gaap Inventory Net
InventoryNet
5538794
CY2019Q2 us-gaap Inventory Net
InventoryNet
6851448
CY2019Q2 us-gaap Liabilities
Liabilities
8163181
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22580406
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
380000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1953031
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1848340
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1563437
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1601300
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3040000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1140000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
380000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
380000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
380000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
380000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
457598
CY2017Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23235282
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2615090
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2997799
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4809218
CY2019Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5165382
CY2020 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
194083
CY2019 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
72019
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
506700
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46677
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-537275
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-310993
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1801702
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1411065
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-465597
CY2019 us-gaap Net Income Loss
NetIncomeLoss
305989
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-484042
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
276308
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
380000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
380000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2582402
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
276947
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
265443
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2305455
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2582402
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
380000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2582402
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2847846
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0425
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0425
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9459229
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9430750
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44622
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
49779
CY2020 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
113116
CY2019 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
123237
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
424159
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
187756
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8606805
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
267647
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
133889
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
506700
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
46677
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8930172
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
983641
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
890110
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
56386
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23422
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
64000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
585000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.45
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8236345
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8701942
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18311830
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21842097
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6146650
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6543566
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
549594
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
515681
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.74
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0187
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0286
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1320291
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1408709
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.12
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
34797
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
302000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
362000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
73000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
555000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
73000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.57
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.26
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
48280
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2405000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2592875
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2721875
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.73
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.11
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.53
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.62
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.22
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.15
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.79
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.08
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y36D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y292D
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9788
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y73D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y222D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1189918
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1272584
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1313166
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
64000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.33
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.39
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.90
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.19
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.26
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y222D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y83D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y299D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
483461
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
374639
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
429334
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
450418
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.87
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.07
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
506700
CY2019Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22125
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
46677
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
45500000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
43360247
CY1995Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
2000000
CY2020 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2019 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
15156098
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15072101
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
14203754
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">USE OF ESTIMATES &#x2014; The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenue and expenses during the reported <div style="display: inline;">periods</div>. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
61948
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-328541
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7404831
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7407827
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7404831
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7401030

Files In Submission

Name View Source Status
0001437749-20-018841-index-headers.html Edgar Link pending
0001437749-20-018841-index.html Edgar Link pending
0001437749-20-018841.txt Edgar Link pending
0001437749-20-018841-xbrl.zip Edgar Link pending
ex_191199.htm Edgar Link pending
ex_191201.htm Edgar Link pending
ex_191202.htm Edgar Link pending
ex_191203.htm Edgar Link pending
ex_191204.htm Edgar Link pending
ex_200591.htm Edgar Link pending
ex_200595.htm Edgar Link pending
ex_201043.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
koss-20200630.xml Edgar Link completed
koss-20200630.xsd Edgar Link pending
koss-20200630_cal.xml Edgar Link unprocessable
koss-20200630_def.xml Edgar Link unprocessable
koss-20200630_lab.xml Edgar Link unprocessable
koss-20200630_pre.xml Edgar Link unprocessable
koss20200630_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending